Works by Schlander, Michael

Results: 62

Measuring the Socioeconomic Impact of Cancer: A Systematic Review and Standardized Assessment of Patient-Reported Outcomes (PRO) Instruments.

Published in:

PharmacoEconomics - Open, 2025, v. 9, n. 4, p. 519, doi. 10.1007/s41669-025-00568-0

By:

Pham, Phu Duy;
Ubels, Jasper;
Eckford, Rachel;
Schlander, Michael

Publication type:

Article

Resource allocation in the Covid-19 health crisis: are Covid-19 preventive measures consistent with the Rule of Rescue?

Published in:

2021

By:

März, Julian W.;
Holm, Søren;
Schlander, Michael

Publication type:

journal article

Gesundheitsökonomie der Krebsfrüherkennung in Deutschland: Welche Interventionen sind kosteneffektiv bei bevölkerungsweiter Umsetzung?

Published in:

Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz, 2018, v. 61, n. 12, p. 1559, doi. 10.1007/s00103-018-2839-3

By:

Schlander, Michael;
Cheng, Chih-Yuan;
Ran, Tao

Publication type:

Article

Availability, accessibility and delivery to patients of the 28 orphan medicines approved by the European Medicine Agency for hereditary metabolic diseases in the MetabERN network.

Published in:

2020

By:

Heard, Jean-Michel;
Vrinten, Charlotte;
Schlander, Michael;
Bellettato, Cinzia Maria;
van Lingen, Corine;
Scarpa, Maurizio;
the MetabERN collaboration group;
Matthijs, Gert;
Nassogne, Marie-Cécile;
Debray, François-Guillaume;
Roland, Dominique;
Chamova, Teodora;
Kozich, Viktor;
Pavel, Jesina;
Zenker, Martin;
Lampe, Christina;
Das, Anihb Martin;
Hennermann, Julia;
Kölker, Stefan;
Weinhold, Natalie

Publication type:

journal article

Projecting Pharmaceutical Expenditure in EU5 to 2021: Adjusting for the Impact of Discounts and Rebates.

Published in:

Applied Health Economics & Health Policy, 2018, v. 16, n. 6, p. 803, doi. 10.1007/s40258-018-0419-1

By:

Espin, Jaime;
Schlander, Michael;
Godman, Brian;
Anderson, Pippa;
Mestre-Ferrandiz, Jorge;
Borget, Isabelle;
Hutchings, Adam;
Flostrand, Steven;
Parnaby, Adam;
Jommi, Claudio

Publication type:

Article

Arzneimittelversorgung und Kostendämpfungspolitik.

Published in:

Medizinische Klinik (Urban & Vogel), 2005, v. 100, n. 6, p. 314, doi. 10.1007/s00063-005-1040-2

By:

Michael Schlander

Publication type:

Article

Health technology assessment (HTA) and economic evaluation: efficiency or fairness first.

Published in:

Journal of Market Access & Health Policy, 2019, v. 7, n. 1, p. 1, doi. 10.1080/20016689.2018.1557981

By:

Richardson, Jeff;
Schlander, Michael

Publication type:

Article

Determining the value of medical technologies to treat ultra-rare disorders: a consensus statement.

Published in:

Journal of Market Access & Health Policy, 2016, v. 4, p. 1, doi. 10.3402/jmahp.v4.33039

By:

Schlander, Michael;
Garattini, Silvio;
Kolominsky-Rabas, Peter;
Nord, Erik;
Persson, Ulf;
Postma, Maarten;
Richardson, Jeff;
Simoens, Steven;
Solà-Morales, Oriol de;
Tolley, Keith;
Toumi, Mondher

Publication type:

Article

Would initiating colorectal cancer screening from age of 45 be cost-effective in Germany? An individual-level simulation analysis.

Published in:

Frontiers in Public Health, 2024, p. 1, doi. 10.3389/fpubh.2024.1307427

By:

Min Wai Lwin;
Chih-Yuan Cheng;
Calderazzo, Silvia;
Schramm, Christoph;
Schlander, Michael

Publication type:

Article

Income loss after a cancer diagnosis in Germany: An analysis based on the socio‐economic panel survey.

Published in:

Cancer Medicine, 2021, v. 10, n. 11, p. 3726, doi. 10.1002/cam4.3913

By:

Hernandez, Diego;
Schlander, Michael

Publication type:

Article

Arzneimittelpreise: Preisbildung in einem besonderen Markt.

Published in:

Deutsches Ärzteblatt International, 2012, v. 109, n. 11, p. 1

By:

Schlander, Michael;
Jäcker, Andreas;
Völkl, Martin

Publication type:

Article

Quality appraisal for systematic literature reviews of health state utility values: a descriptive analysis.

Published in:

2022

By:

Muchadeyi, Muchandifunga Trust;
Hernandez-Villafuerte, Karla;
Schlander, Michael

Publication type:

journal article

Health and life insurance-related problems in very long-term cancer survivors in Germany: a population-based study.

Published in:

Journal of Cancer Research & Clinical Oncology, 2022, v. 148, n. 1, p. 155, doi. 10.1007/s00432-021-03825-x

By:

Thong, Melissa S. Y.;
Doege, Daniela;
Weißer, Linda;
Koch-Gallenkamp, Lena;
Bertram, Heike;
Eberle, Andrea;
Holleczek, Bernd;
Nennecke, Alice;
Waldmann, Annika;
Zeissig, Sylke Ruth;
Pritzkuleit, Ron;
Schlander, Michael;
Brenner, Hermann;
Arndt, Volker

Publication type:

Article

Modeling the Natural History and Screening Effects of Colorectal Cancer Using Both Adenoma and Serrated Neoplasia Pathways: The Development, Calibration, and Validation of a Discrete Event Simulation Model.

Published in:

MDM Policy & Practice, 2023, v. 8, n. 1, p. 1, doi. 10.1177/23814683221145701

By:

Chih-Yuan Cheng;
Calderazzo, Silvia;
Schramm, Christoph;
Schlander, Michael

Publication type:

Article

PD68 A Cross-Cultural Validation Study Of The German And English Versions Of The ICEpop CAPability measure for Adults (ICECAP-A).

Published in:

International Journal of Technology Assessment in Health Care, 2025, v. 40, p. S123, doi. 10.1017/S0266462324003258

By:

Ubels, Jasper;
Schlander, Michael

Publication type:

Article

PD07 Can Commencing Colorectal Cancer Screening At Age 45 Years Be A Good Investment? An Individual-Level Simulation Analysis In Germany.

Published in:

International Journal of Technology Assessment in Health Care, 2025, v. 40, p. S100, doi. 10.1017/S0266462324002769

By:

Lwin, Min Wai;
Cheng, Chih-Yuan;
Calderazzo, Silvia;
Schramm, Christoph;
Schlander, Michael

Publication type:

Article

PP74 Are Commonly Used Cost-Effectiveness Thresholds Too Low? Empirical Evidence From Economic Studies On The Value Of Life.

Published in:

International Journal of Technology Assessment in Health Care, 2025, v. 40, p. S85, doi. 10.1017/S0266462324002435

By:

Schlander, Michael;
Hernandez, Diego;
Schwarz, Oliver;
Schaefer, Ramon

Publication type:

Article

OD45 Evaluating Quality In Health Economics: Quality Appraisal Checklist For Systematic Reviews Of Studies Eliciting Health State Utility Values.

Published in:

International Journal of Technology Assessment in Health Care, 2025, v. 40, p. S52, doi. 10.1017/S0266462324001727

By:

Muchadeyi, Muchandifunga T.;
Hernandez-Villafuerte, Karla;
Di Tanna, Gian Luca;
Eckford, Rachel;
Feng, Yan;
Meregaglia, Michela;
Peasgood, Tessa;
Petrou, Stavros;
Ubels, Jasper;
Schlander, Michael

Publication type:

Article

OD23 Evolving Prostate Cancer Screening Strategies In Germany: A Cost–Utility Analysis Comparing Traditional And Emerging Modalities.

Published in:

International Journal of Technology Assessment in Health Care, 2025, v. 40, p. S43, doi. 10.1017/S0266462324001557

By:

Muchadeyi, Muchandifunga T.;
Hao, Shuang;
Hernandez-Villafuerte, Karla;
Khan, Shah;
Becker, Nikolaus;
Krilaviciute, Agne;
Seibold, Petra;
Gulati, Roman;
Albers, Peter;
Schlander, Michael;
Clements, Mark

Publication type:

Article

PD49 Social Preferences In HTA: A Pilot Analysis In CLN2 Disease.

Published in:

2018

By:

Bakshi, Sumeet;
Schlander, Michael;
Telser, Harry;
Sola-Morales, Oriol;
Moro, Domenico;
Butt, Thomas;
Olaye, Andrew;
Jain, Mohit

Publication type:

Abstract

PP149 Features Of Accountable And Reasonable Processes For Coverage Decision-Making.

Published in:

2018

By:

Wagner, Monika;
Samaha, Dima;
Casciano, Roman;
Brougham, Matthew;
Petrie, Charles;
Abrishami, Payam;
Avouac, Bernard;
Kind, Paul;
Mantovani, Lorenzo Giovanni;
Sarria-Santamera, Antonio;
Schlander, Michael;
Tringali, Michele

Publication type:

Abstract

PP98 Efficacy Of The Multi-Attribute Utility Instruments To Reflect Quality Of Life Of Cancer Patients.

Published in:

2018

By:

Hernandez-Villafuerte, Karla;
Ubels, Jasper;
Carreno, Diego Andres Hernandez;
Schlander, Michael

Publication type:

Abstract

VP95 The Monetary Value Of A Statistical Life Year: A Systematic Review.

Published in:

2017

By:

Schwarz, Oliver;
Schaefer, Ramon;
Schlander, Michael

Publication type:

Abstract

OP95 An Update On The Economic Value Of A Statistical Life Year In Europe.

Published in:

2017

By:

Schaefer, Ramon;
Schwarz, Oliver;
Schlander, Michael

Publication type:

Abstract

OP94 Is The National Institute for Health And Care Excellence In The United Kingdom More Innovation-Friendly Than The German Institute For Quality And Efficiency in Health Care In Germany?

Published in:

2017

By:

Schaefer, Ramon;
Schlander, Michael

Publication type:

Abstract

Survival and comorbidities in lung cancer patients: Evidence from administrative claims data in Germany.

Published in:

Oncology Research, 2022, v. 30, n. 4, p. 173, doi. 10.32604/or.2022.027262

By:

HERNANDEZ, DIEGO;
CHIH-YUAN CHENG;
HERNANDEZ-VILLAFUERTE, KARLA;
SCHLANDER, MICHAEL

Publication type:

Article

Use of the incremental cost-effectiveness ratio for decision-making policies—what is the problem? A perspective paper.

Published in:

Expert Review of Pharmacoeconomics & Outcomes Research, 2022, v. 22, n. 6, p. 913, doi. 10.1080/14737167.2022.2064847

By:

Brougham, Matthew;
Schlander, Michael;
Telser, Harry;
Bakshi, Sumeet;
Sola-Morales, Oriol

Publication type:

Article

Evaluating discrete choice experiment willingness to pay [DCE-WTP] analysis and relative social willingness to pay [RS-WTP] analysis in a health technology assessment of a treatment for an ultra-rare childhood disease [CLN2].

Published in:

Expert Review of Pharmacoeconomics & Outcomes Research, 2022, v. 22, n. 4, p. 581, doi. 10.1080/14737167.2022.2014324

By:

Moro, Domenico;
Schlander, Michael;
Telser, Harry;
Sola-Morales, Oriol;
Clark, Michael David;
Olaye, Andrew;
Camp, Charlotte;
Jain, Mohit;
Butt, Thomas;
Bakshi, Sumeet

Publication type:

Article

Is the National Institute for Health and Care Excellence (NICE) in England more 'innovation-friendly' than the Federal Joint Committee (G-BA) in Germany?

Published in:

2019

By:

Schaefer, Ramon;
Schlander, Michael

Publication type:

journal article

Budget impact analysis of drugs for ultra-orphan non-oncological diseases in Europe.

Published in:

Expert Review of Pharmacoeconomics & Outcomes Research, 2015, v. 15, n. 1, p. 171, doi. 10.1586/14737167.2015.965156

By:

Schlander, Michael;
Adarkwah, Charles Christian;
Gandjour, Afschin

Publication type:

Article

Determining the price for pharmaceuticals in Germany: comparing a shortcut for IQWiG's efficiency frontier method with the price set by the manufacturer for ticagrelor.

Published in:

Expert Review of Pharmacoeconomics & Outcomes Research, 2014, v. 14, n. 1, p. 123, doi. 10.1586/14737167.2014.868313

By:

Gandjour, Afschin;
Gafni, Amiram;
Schlander, Michael

Publication type:

Article

Measurement invariance and adapted preferences: evidence for the ICECAP-A and WeRFree instruments.

Published in:

Health & Quality of Life Outcomes, 2023, v. 21, n. 1, p. 1, doi. 10.1186/s12955-023-02208-9

By:

Ubels, Jasper;
Schlander, Michael

Publication type:

Article

ADHD in Germany: Trends in Diagnosis and Pharmacotherapy.

Published in:

2017

By:

Schlander, Michael;
Schwarz, Oliver;
Trott, Götz-Erik;
Bachmann, Christian J.;
Philipsen, Alexandra;
Hoffmann, Falk

Publication type:

Letter to the Editor

The cost incurred by victims of bullying from a societal perspective: estimates based on a German online survey of adolescents.

Published in:

European Child & Adolescent Psychiatry, 2019, v. 28, n. 4, p. 585, doi. 10.1007/s00787-018-1224-y

By:

Jantzer, Vanessa;
Schlander, Michael;
Haffner, Johann;
Parzer, Peter;
Trick, Sarah;
Resch, Franz;
Kaess, Michael

Publication type:

Article

Has NICE got it right? An international perspective considering the case of Technology Appraisal No. 98 by the National Institute for Health and Clinical Excellence (NICE).

Published in:

Current Medical Research & Opinion, 2008, v. 24, n. 4, p. 951, doi. 10.1185/030079908X280428

By:

Michael Schlander

Publication type:

Article

Is NICE infallible? A qualitative study of its assessment of treatments for attention-deficit/hyperactivity disorder (ADHD).

Published in:

Current Medical Research & Opinion, 2008, v. 24, n. 2, p. 515, doi. 10.1185/030079908X260808

By:

Michael Schlander

Publication type:

Article

NICE accountability for reasonableness: a qualitative study of its appraisal of treatments for attention-deficit/hyperactivity disorder (ADHD).

Published in:

2007

By:

Schlander M;
Schlander, Michael

Publication type:

journal article

NICE accountability for reasonableness: a qualitative study of its appraisal of treatments for attention-deficit/hyperactivity disorder (ADHD).

Published in:

Current Medical Research & Opinion, 2007, v. 23, n. 1, p. 207, doi. 10.1185/030079906X159461

By:

Michael Schlander

Publication type:

Article

Developing a Conceptual Framework for Socioeconomic Impact Research in European Cancer Patients: A 'Best-Fit' Framework Synthesis.

Published in:

Patient, 2023, v. 16, n. 5, p. 515, doi. 10.1007/s40271-023-00632-z

By:

Pham, Phu Duy;
Schlander, Michael;
Eckford, Rachel;
Hernandez-villafuerte, Karla;
Ubels, Jasper

Publication type:

Article

Optimal timing of a colonoscopy screening schedule depends on adenoma detection, adenoma risk, adherence to screening and the screening objective: A microsimulation study.

Published in:

PLoS ONE, 2024, v. 19, n. 5, p. 1, doi. 10.1371/journal.pone.0304374

By:

Zaika, Viktor;
Prakash, Meher K.;
Cheng, Chih-Yuan;
Schlander, Michael;
Lang, Brian M.;
Beerenwinkel, Niko;
Sonnenberg, Amnon;
Krupka, Niklas;
Misselwitz, Benjamin;
Poleszczuk, Jan

Publication type:

Article

Who cares for patients with attention-deficit/hyperactivity disorder (ADHD)?

Published in:

European Child & Adolescent Psychiatry, 2007, v. 16, n. 7, p. 430, doi. 10.1007/s00787-007-0616-1

By:

Schlander, Michael;
Schwarz, Oliver;
Trott, Goetz-Erik;
Viapiano, Michael;
Bonauer, Norbert

Publication type:

Article

Long-acting medications for the hyperkinetic disorders.

Published in:

European Child & Adolescent Psychiatry, 2007, v. 16, n. 7, p. 421, doi. 10.1007/s00787-007-0615-2

By:

Schlander, Michael

Publication type:

Article

Quality Appraisal in Systematic Literature Reviews of Studies Eliciting Health State Utility Values: Conceptual Considerations.

Published in:

PharmacoEconomics, 2024, v. 42, n. 7, p. 767, doi. 10.1007/s40273-024-01365-z

By:

Muchadeyi, Muchandifunga Trust;
Hernandez-Villafuerte, Karla;
Di Tanna, Gian Luca;
Eckford, Rachel D.;
Feng, Yan;
Meregaglia, Michela;
Peasgood, Tessa;
Petrou, Stavros;
Ubels, Jasper;
Schlander, Michael

Publication type:

Article

How Much Does It Cost to Research and Develop a New Drug? A Systematic Review and Assessment.

Published in:

PharmacoEconomics, 2021, v. 39, n. 11, p. 1243, doi. 10.1007/s40273-021-01065-y

By:

Schlander, Michael;
Hernandez-Villafuerte, Karla;
Cheng, Chih-Yuan;
Mestre-Ferrandiz, Jorge;
Baumann, Michael

Publication type:

Article

Determining Value in Health Technology Assessment: Stay the Course or Tack Away?

Published in:

2019

By:

Caro, J. Jaime;
Brazier, John E.;
Karnon, Jonathan;
Kolominsky-Rabas, Peter;
McGuire, Alistair J.;
Nord, Erik;
Schlander, Michael

Publication type:

journal article

Anxiety and depression in cancer patients and survivors in the context of restrictions in contact and oncological care during the COVID‐19 pandemic.

Published in:

International Journal of Cancer, 2025, v. 156, n. 4, p. 711, doi. 10.1002/ijc.35204

By:

Doege, Daniela;
Frick, Julien;
Eckford, Rachel D.;
Koch‐Gallenkamp, Lena;
Schlander, Michael;
Arndt, Volker;
Bergbold, Susanne;
Hermann, Silke;
Schuldt, Dagmar

Publication type:

Article

Do certified cancer centers provide more cost‐effective care? A health economic analysis of colon cancer care in Germany using administrative data.

Published in:

International Journal of Cancer, 2021, v. 149, n. 10, p. 1744, doi. 10.1002/ijc.33728

By:

Cheng, Chih‐Yuan;
Datzmann, Thomas;
Hernandez, Diego;
Schmitt, Jochen;
Schlander, Michael

Publication type:

Article

Cost‐effectiveness of risk‐based breast cancer screening: A systematic review.

Published in:

International Journal of Cancer, 2021, v. 149, n. 4, p. 790, doi. 10.1002/ijc.33593

By:

Khan, Shah Alam;
Hernandez‐Villafuerte, Karla Vanessa;
Muchadeyi, Muchandifunga Trust;
Schlander, Michael

Publication type:

Article

Reply to: Comments on "Cost of decentralized CAR T cell production in an academic non‐profit setting".

Published in:

International Journal of Cancer, 2021, v. 148, n. 2, p. 516, doi. 10.1002/ijc.33253

By:

Ran, Tao;
Eichmüller, Stefan B.;
Schmidt, Patrick;
Schlander, Michael

Publication type:

Article

Cost of decentralized CAR T‐cell production in an academic nonprofit setting.

Published in:

International Journal of Cancer, 2020, v. 147, n. 12, p. 3438, doi. 10.1002/ijc.33156

By:

Ran, Tao;
Eichmüller, Stefan B.;
Schmidt, Patrick;
Schlander, Michael

Publication type:

Article